Antimicrobial susceptibilities of Porphyromonas gingivalis, Prevotella intermedia, and Prevotella nigrescens spp. isolated in Spain

被引：45

作者：

Andrés, MT

Chung, WO

Roberts, MC

Fierro, JF

机构：

[1] Univ Oviedo, Fac Med, Dept Funct Biol Microbiol, E-33006 Oviedo, Spain

[2] Univ Oviedo, Sch Stomatol, Lab Oral Microbiol, E-33006 Oviedo, Spain

[3] Univ Washington, Dept Pathobiol, Seattle, WA 98195 USA

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1998年 / 42卷 / 11期

关键词：

D O I：

10.1128/AAC.42.11.3022

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The susceptibilities of 143 Porphyromonas gingivalis, Prevotella intermedia, and Prevotella nigrescens isolates to 18 antimicrobial agents were tested. All P. gingivalis isolates were susceptible. In contrast, some Prevotella spp. (17%) were resistant to beta-lactams, erythromycin, clindamycin, or tetracycline and carried resistance genes, ermF or tetQ, or beta-lactamases.

引用

页码：3022 / 3023

页数：2

共 15 条

[1] IMMUNOMAGNETIC PCR AND DNA-PROBE FOR DETECTION AND IDENTIFICATION OF PORPHYROMONAS-GINGIVALIS [J].

BENKIRANE, RM ;

GUILLOT, E ;

MOUTON, C .

JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (11) :2908-2912

[2] β-lactamase-producing strains in the species Prevotella intermedia and Prevotella nigrescens [J].

Bernal, LA ;

Guillot, E ;

Paquet, C ;

Mouton, C .

ORAL MICROBIOLOGY AND IMMUNOLOGY, 1998, 13 (01) :36-40

[3] SYNERGY BETWEEN SPIRAMYCIN AND METRONIDAZOLE IN THE TREATMENT OF POLYMICROBIAL INFECTIONS [J].

BROOK, I .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1988, 22 :77-85

[4] Optimized oligonucleotides for the differentiation of Prevotella intermedia and Prevotella nigrescens [J].

Conrads, G ;

Pelz, K ;

Hughes, B ;

Seyfarth, I ;

Devine, DA .

ORAL MICROBIOLOGY AND IMMUNOLOGY, 1997, 12 (02) :117-120

[5] DETECTION OF CONJUGAL TRANSFER SYSTEMS IN ORAL, BLACK-PIGMENTED BACTEROIDES SPP [J].

GUINEY, DG ;

BOUIC, K .

JOURNAL OF BACTERIOLOGY, 1990, 172 (01) :495-497

[6] SUSCEPTIBILITY OF ANAEROBES IN PHASE-3 CLINICAL-STUDIES OF PIPERACILLIN TAZOBACTAM [J].

JACOBUS, NV ;

IMMERMANN, FW ;

GUPTE, JM ;

TESTA, RT .

CLINICAL INFECTIOUS DISEASES, 1993, 16 :S344-S348

[7] Distribution and mobility of the tetracycline resistance determinant tetQ [J].

Leng, ZT ;

Riley, DE ;

Berger, RE ;

Krieger, JN ;

Roberts, MC .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (04) :551-559

[8]

Matto J, 1997, CLIN INFECT DIS, V25, pS194

[9]

*NAT COMM CLIN LAB, 1997, M11A4 NAT COMM CLIN

[10]

PAJUKANTA R, 1993, FEMS IMMUNOL MED MIC, V6, P241

← 1 2 →